Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another. Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a ...

Guess logo is seen at a store in Krakow, Poland on January 24, 2024. (Photo by Jakub Porzycki/NurPhoto via Getty Images)NurPhoto via Getty Images Guess Stock (NYSE: GES) is entering a crucial stage, revealing its intentions to privatize through a $1.4 billion agreement with co-founders Maurice and Paul Marciano, CEO Carlos Alberini, and Authentic Brands, the owner of Reebok. Authentic Brands will obtain 51% of Guess’s intellectual property, while the remaining shares will remain with current shareholders. S ...

Sometimes you just have to pay for quality. I advocate this no more than with IRadimed Corporation (NASDAQ: IRMD ), a business with among the most exceptional economic characteristics I have come across inEquity strategist (US Equities)Technical focus on fundamental value drivers of business economics to uncover high probability long-term compounders. Seeking to buy at appropriate prices relative to intrinsic worth. Partners are represented over the cross-section of financial markets, from speculators, hedg ...

Key Takeaways PVH expects Q2 revenues of $2.1B, up 1.3%, and EPS of $1.97, down 34.6% year over year.Brand portfolio and PVH+ Plan support growth through marketing and global expansion.Margin pressure persists from promotions, higher costs, and weak consumer sentiment.PVH Corporation (PVH) is likely to post a year-over-year decline in its bottom line when it reports second-quarter fiscal 2025 results on Aug. 26, after market close. The Zacks Consensus Estimate for quarterly revenues is pegged at $2.1 billio ...

Key Takeaways Estimates for GBX's 2025 earnings rose 28%, reflecting brokers' confidence in growth.GBX shares gained 3.2% in 90 days, topping the industry's 0.2% decline over the same period.Q3 results saw an 18% gross margin, $140M cash flow and a $2.5B railcar backlog.The Greenbrier Companies (GBX) is benefiting from its robust operational efficiency, boosting its prospects. The company’s shareholder-friendly initiatives are also commendable. Due to these tailwinds, GBX shares have performed impressively ...

Key Takeaways Lam Research trades at a 22.33 forward P/E, below industry and key peers like KLAC and ASML.LRCX's revenues jumped 34% to $5.17B in Q4 2025, with EPS surging 64% year over year.China made up 34% of LRCX revenues, down from 42%, amid trade tensions and export curbs.Lam Research Corporation (LRCX) , a leader in semiconductor fabrication equipment, currently trades at a forward 12-month price-to-earnings (P/E) ratio of 22.32, significantly lower than the Zacks Electronics – Semiconductors industr ...

Core Viewpoint - Shares of Hewlett Packard Enterprise Co (HPE) have increased by 3% to $21.66 following a Morgan Stanley upgrade to "overweight" from "equal weight," with a price target raised to $28 from $22, driven by the company's acquisition of Juniper Networks for $14 billion and positive AI demand outlook [1]. Group 1 - HPE's stock has shown volatility since hitting a two-year low of $11.96 on April 4, currently fluctuating between $20 and $22, with a peak of $24.66 in January [2]. - Year-to-date performance has improved, with shares returning to positive territory after today's increase [2]. - Analyst sentiment is mixed, with nine out of 18 analysts recommending a "hold," indicating potential for further bullish upgrades if bearish sentiment diminishes [2]. Group 2 - Options for HPE are currently reasonably priced, with a Schaeffer's Volatility Index (SVI) of 47%, placing it in the low 27th percentile of its annual range, suggesting low volatility expectations among options traders [3].

Core Viewpoint - A class action lawsuit has been filed against Altimmune Inc. by Berger Montague on behalf of investors who acquired the company's securities during the specified class period from August 10, 2023, to June 25, 2025 [1][2]. Company Overview - Altimmune Inc. is a clinical-stage biopharmaceutical company based in Gaithersburg, Maryland, focusing on therapeutics for obesity and liver disease, including MASH (metabolic dysfunction-associated steatohepatitis) [2]. Legal Action Details - Investors who purchased Altimmune securities during the class period have until October 6, 2025, to seek appointment as lead plaintiff representatives [2]. - The lawsuit follows a press release from Altimmune on June 26, 2025, announcing disappointing results from its IMPACT Phase 2b trial of Pemvidutide for MASH treatment, where the primary endpoint of fibrosis reduction did not achieve statistical significance [3]. Stock Price Impact - Following the announcement of the trial results, Altimmune's stock price plummeted by 53.2% in one day, dropping from a closing price of $7.71 on June 25, 2025, to $3.61 on June 26, 2025 [4].

Core Viewpoint - The complaint against Unicycive alleges violations of federal securities laws due to false or misleading statements regarding the company's compliance with FDA manufacturing requirements and the regulatory prospects of its OLC NDA [2]. Group 1: Company Performance and Regulatory Issues - On June 10, 2025, Unicycive announced that the FDA identified deficiencies in cGMP compliance at a third-party manufacturing vendor, leading to a significant stock price drop of $3.68 per share, or 40.89%, closing at $5.32 [3]. - On June 30, 2025, Unicycive disclosed that the FDA issued a Complete Response Letter for the OLC NDA, citing the same cGMP deficiencies, resulting in a further stock price decline of $2.03 per share, or 29.85%, closing at $4.77 [4]. Group 2: Legal Proceedings - The lead plaintiff in the class action lawsuit is the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [5]. - Any member of the putative class can move to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [5]. Group 3: Whistleblower Information - The law firm Faruqi & Faruqi encourages individuals with information regarding Unicycive's conduct, including whistleblowers and former employees, to come forward [6].

Core Viewpoint - BitMine Immersion Technologies has transformed from a Bitcoin mining operator to a leader in the digital asset space, controlling a treasury valued at over $6.6 billion while its stock market valuation is only around $215 million, indicating a significant value gap [1][2][6]. Group 1: Company Transformation - The company has adopted an aggressive strategy called "The Alchemy of 5%" aimed at acquiring 5% of the total circulating supply of Ethereum, coinciding with rising institutional interest in Ethereum as a foundational technology for finance [2][3]. - BitMine has rapidly increased its Ethereum holdings from 625,000 ETH in late July to 1,523,373 ETH by mid-August, establishing itself as the largest corporate holder of Ethereum globally [5][6]. Group 2: Value Assessment - The company's treasury, consisting of Ethereum and cash, is valued at over $6.6 billion, creating a stark contrast with its stock price of approximately $50 per share, suggesting a significant undervaluation [4][6]. - The average daily trading volume of BitMine's stock has surged to $6.4 billion, making it one of the top 10 most liquid stocks in the U.S., which provides institutional-level access [7]. Group 3: Strategic Actions - To address the valuation gap, BitMine's Board of Directors approved a $1 billion stock repurchase program, signaling management's belief in the stock's undervaluation and aiming to increase NAV per share for remaining shareholders [9][10][11]. - The company has garnered attention from prominent institutional investors, including Cathie Wood and Bill Miller III, which adds credibility to its Ethereum-focused strategy [12][13]. Group 4: Investment Opportunity - BitMine represents a unique publicly-traded vehicle for investors to gain exposure to a growing Ethereum treasury at a potential discount to its intrinsic asset value [15]. - The company's focused strategy, strong institutional backing, and active management efforts to create shareholder value make it a compelling investment opportunity in the cryptocurrency space [17].